Cargando…
MicroRNAs and Long Noncoding RNAs as Novel Therapeutic Targets in Estrogen Receptor-Positive Breast and Ovarian Cancers
Aromatase inhibitors (AIs) such as anastrozole, letrozole, and exemestane have shown to prevent metastasis and angiogenesis in estrogen receptor (ER)-positive breast and ovarian tumors. They function primarily by reducing estrogen production in ER-positive post-menopausal breast and ovarian cancer p...
Autores principales: | Barwal, Tushar Singh, Sharma, Uttam, Bazala, Sonali, Singh, Ipsa, Jain, Manju, Prakash, Hridayesh, Shekhar, Shashank, Sandberg, Elise N., Bishayee, Anupam, Jain, Aklank |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8071157/ https://www.ncbi.nlm.nih.gov/pubmed/33920789 http://dx.doi.org/10.3390/ijms22084072 |
Ejemplares similares
-
A Pleiotropic Role of Long Non-Coding RNAs in the Modulation of Wnt/β-Catenin and PI3K/Akt/mTOR Signaling Pathways in Esophageal Squamous Cell Carcinoma: Implication in Chemotherapeutic Drug Response
por: Sharma, Uttam, et al.
Publicado: (2022) -
Long Non-Coding RNAs as Strategic Molecules to Augment the Radiation Therapy in Esophageal Squamous Cell Carcinoma
por: Sharma, Uttam, et al.
Publicado: (2020) -
The imminent role of microRNAs in salivary adenoid cystic carcinoma
por: Kumar, Pawan, et al.
Publicado: (2022) -
The regulatory roles of long non-coding RNAs in the development of chemoresistance in breast cancer
por: Malhotra, Akshay, et al.
Publicado: (2017) -
Cancer Susceptibility Candidate 9 (CASC9): A Novel Targetable Long Noncoding RNA in Cancer Treatment
por: Sharma, Uttam, et al.
Publicado: (2020)